Spok Holdings, Inc.

Spok Holdings, Inc.

SPOKNYSE / NASDAQHealthcareSmall cap

$10.76+$0.11 (+1.0%)

Last close · Data as of Nov 20, 2026

Market cap
$228.3M
P/E
14.4x
EV / EBITDA
8.9x
Revenue
$139.7M
Net margin
11.4%
ROCE
12.8%

-13.4% over the last year

Spok Holdings, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+2.0%
3M
+3.1%
6M
-2.5%
1Y
-13.4%
5Y
+10.1%

52-week range

Day change +$0.11 (+1.0%) from $10.65 to $10.76 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in SPOK, bought on each weekday since 2021.

News & filings

What Spok Holdings filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthThe company carries almost no debt: debt to equity of 0.05.

Concerns (1)

  • Revenue grew 1.3% a year over three years.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance.

Read moreShow less

Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance. The company delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager. It offers subscriptions to one-way or two-way messaging services, as well as alphanumeric pagers that are configurable to support unencrypted or encrypted operation; and ancillary services, such as voicemail, and equipment loss or maintenance protection services, as well as sells devices to resellers who lease or resell them to their subscribers. The company provides Spok Care Connect suite products for contact centers, clinical alerting and notification, mobile communications and messaging, and public safety notifications. In addition, it provides professional, software license updates, and product support services, as well as sells third-party equipment. It serves businesses, professionals, management personnel, medical personnel, field sales personnel and service forces, members of the construction industry and construction trades, real estate brokers and developers, sales and services organizations, specialty trade organizations, manufacturing organizations, and government agencies. The company was formerly known as USA Mobility, Inc. and changed its name to Spok Holdings, Inc. in July 2014. Spok Holdings, Inc. was founded in 1986 and is headquartered in Plano, Texas.

Sector
Healthcare
Shares outstanding
20.6M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$228.3M
P/E
14.4x
P/B
1.6x
EV / EBITDA
8.9x
EV / Sales
1.5x
P/S
1.6x
52-week high
$13.82
52-week low
$10.11

Profitability

Operating margin
14.4%
Net margin
11.4%
EBITDA margin
16.9%
ROE
10.8%
ROCE
12.8%
ROIC
11.7%
ROA
7.7%
Asset turnover
0.68

Growth

Revenue
$139.7M
Revenue growth, 1Y
1.5%
Revenue CAGR, 3Y
1.3%
Net profit growth, 1Y
6.1%
Free cash flow
$25.2M

Solvency

Current ratio
1.18
Debt / Equity
0.05
Debt / Assets
0.03
CFO / Net profit
1.82
Cash / Market cap
11.1%

Where the revenue went

Of every $100 of FY2025 revenue, $11 was left as net income.

Spok Holdings, Inc. income statement flow, FY2025
Spok Holdings, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$29.8M
RevenueGross profit$109.9M
Gross profitResearch and development$12.2M
Gross profitSelling, general and administrative$49.5M
Gross profitOther operating expenses$28.0M
Gross profitOperating income$20.2M
Operating incomePretax income$20.2M
Interest and other incomePretax income$1.3M
Pretax incomeTax and other$5.6M
Pretax incomeNet income$15.9M

Revenue and net profit

Revenue grew 1.5% in FY2025; net profit is the dashed line.

Spok Holdings, Inc. revenue and net profit by fiscal year
Spok Holdings, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$134.5M$21.9M
FY2023$139.0M$15.7M
FY2024$137.7M$15.0M
FY2025$139.7M$15.9M

Cash flows

FY2025: $28.9M from operations, $25.2M free after investment (dashed).

Spok Holdings, Inc. operating and free cash flow by fiscal year
Spok Holdings, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$6.5M$2.7M
FY2023$26.2M$22.8M
FY2024$28.9M$25.7M
FY2025$28.9M$25.2M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$139.7M+1.5%1Y
EBITDA
$23.6M-2.6%1Y
Net profit
$15.9M+6.1%1Y
Cash from operations
$28.9M+0.1%1Y
Free cash flow
$25.2M-2.0%1Y
Revenue CAGR, 3Y
1.3%
Net profit CAGR, 3Y
-10.1%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$139.7M$23.6M$15.9M$25.2M10.8%+1.5%+6.1%

Monthly returns

Month-by-month returns of SPOK across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$206.1M
Liabilities$59.7M
Equity$146.4M
Paid-in capital$108.2M
Retained earnings$39.9M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; SPOK highlighted.

P/E against peers

SPOK trades at 14.4x earnings against a peer median of -3.2x.

  1. Spok Holdings, Inc. (this company)14.4x

Not shown (no positive earnings and no EV / Sales): Fulcrum Therapeutics, Inc., Inhibikase Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Spok Holdings, Inc.SPOKthis company$228.3M14.4x1.6x10.8%8.9x
Treace Medical Concepts, Inc.TMCI$239.4M-4.1x2.7x-67.6%-7.0x
LifeMD, Inc.LFMD$235.5M16.4x10.2x62.0%-135.2x
Arcturus Therapeutics Holdings Inc.ARCT$228.5M-3.5x1.1x-30.7%-0.4x
LENZ Therapeutics, Inc.LENZ$225.8M—0.8x-28.9%—
Fulcrum Therapeutics, Inc.FULC$224.6M—0.6x-21.5%—
Foghorn Therapeutics Inc.FHTX$219.6M-3.0x-2.0x68.5%-2.3x
Inhibikase Therapeutics, Inc.IKT$219.2M-4.5x1.3x-27.9%-1.5x
Voyager Therapeutics, Inc.VYGR$218.7M-1.8x1.1x-61.1%-1.5x
Peer median—-3.2x1.1x-28.4%-1.9x

Year-to-date ROI

SPOK since 1 January, against earlier years.

Historical volatility

SPOK's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Spok Holdings, Inc. operating margin by fiscal year
Spok Holdings, Inc. operating margin by fiscal year
DateOperating margin
FY20225.6%
FY202315.7%
FY202414.6%
FY202514.4%
LineFY2025
Cost of revenueCost Of Revenue$29.8M
Gross profitGross Profit$109.9M
Operating expensesOperating Expense$89.8M
Research and developmentResearch And Development$12.2M
Other operating expensesOther Operating Expenses$24.6M
Depreciation and amortisationDepreciation And Amortization In Income Statement$3.4M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$3.4M
Depreciation income statementDepreciation Income Statement$3.4M
Amortization—
Amortisation of intangiblesAmortization Of Intangibles Income Statement—
Rent expense supplementalRent Expense Supplemental—
Total expensesTotal Expenses$119.5M
Pretax incomePretax Income$21.4M

Learn while you research

Academy chapters picked for Spok Holdings, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →